The recall affects 15mg/ml (75 mg/5ml) nizatidine oral solutions packaged in 480 ml bottles the ndc number for the recalled medication is 60846-301-15 with lot numbers that include 06598004a. Acid reflux medication on recall. (rxwiki news) the us food and drug administration (fda) has released an update about the recall of a common heartburn medication the fda has discovered that some medications used for acid reflux contain low levels of a possible cancer-causing impurity these medications are found under the names ranitidine (active ingredient) and zantac (brand) these drugs are available over the counter and.
acid reflux medication on recall
The recalls, posted by the food and drug administration (fda) this week, are the latest in a series that began in september 2019, when the fda alerted the public to the presence of a probable human carcinogen, n-nitrosodimethylamine (ndma), in some ranitidine medications ranitidine is the generic form of zantac. These medications work to prevent heartburn and provide relief tied to acid ingestion by reducing the amount of acid the stomach makes. the prescription version is used to treat and prevent ulcers of the stomach; it also treats gastroesophageal reflux disease (gerd). this recall was recently expanded to include the following products:. A probable carcinogen that prompted the recall of several versions of blood pressure-lowering pills has been detected in the heartburn drug zantac and its generic versions, the food and drug.
